Every 10-Q that SELECT MEDICAL HOLDINGS CORP (SEM) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow SEM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SEM filings page.
Select Medical Holdings Corporation reported mixed Q1 2026 results and advanced its go‑private merger plan. Revenue rose to $1,421.5 million from $1,353.2 million, driven mainly by a 14.5% increase in rehabilitation hospital revenue and 4.5% growth in outpatient rehabilitation.
Net income declined to $63.8 million from $74.7 million, and earnings per share fell to $0.35 from $0.44 as cost of services rose faster than revenue, compressing the total Adjusted EBITDA margin to 10.0% from 11.2%. Critical illness recovery hospitals saw lower occupancy and Adjusted EBITDA, while rehabilitation hospitals benefited from higher patient days and slightly better pricing.
The company ended March 31, 2026 with $6.04 billion in total assets, $1.86 billion of total debt and $25.7 million of cash, generating $37.9 million of operating cash flow in the quarter. Select also highlighted its pending all‑cash merger, under which stockholders are expected to receive $16.50 per share, supported by an $880.0 million equity commitment and committed debt financing, subject to shareholder and regulatory approvals.
Select Medical Holdings (SEM) reported Q3 results with revenue of $1,363,445 thousand, up from $1,271,582 thousand a year ago. Income from continuing operations, net of tax, was $44,180 thousand versus $41,276 thousand, and EPS from continuing operations was $0.23 versus $0.19. Adjusted EBITDA reached $111,655 thousand compared with $103,898 thousand.
By segment, revenue was $609,929 thousand in Critical Illness Recovery Hospitals, $328,607 thousand in Rehabilitation Hospitals, and $325,383 thousand in Outpatient Rehabilitation. For the nine months ended September 30, 2025, revenue was $4,056,196 thousand and income from continuing operations, net of tax, was $176,791 thousand, with EPS from continuing operations of $1.00. Operating cash flow for the period was $282,142 thousand, and capital expenditures were $170,125 thousand. Total debt had a carrying value of $1,772,149 thousand. As of September 30, 2025, SEM had 123,817,591 shares outstanding.